Medicare Enrolled
Dr. Mukesh Shah, M.D
Internal Medicine · Jackson, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Shah from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Shah?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Shah
Dr. Mukesh Shah is an internal medicine specialist in Jackson, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Shah performed 5,177 Medicare services across 2,921 unique beneficiaries.
Between the years covered by Open Payments, Dr. Shah received a total of $7,142 from 51 pharmaceutical and/or device companies across 443 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Shah is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 5% volume in NJ
$7,142 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,177
Medicare services
Top 5% in NJ for internal medicine
2,921
Unique beneficiaries
$61
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~259 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
1,412 | $66 | $125 |
| Nursing facility visit, low complexity A daily follow-up visit for an existing patient in a nursing facility involving straightforward medical decision making. The visit requires at least 15 minutes of time if time is used to determine the level of care. |
859 | $62 | $100 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
353 | $48 | $110 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
328 | $52 | $131 |
| Hospital discharge management, 30+ min This service covers the care provided by a physician or qualified healthcare professional on the day a patient is discharged from the hospital. It requires more than 30 minutes of total time spent on the day of discharge. |
276 | $96 | $175 |
| Annual alcohol misuse screening, 5 to 15 minutes | 227 | $20 | $28 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
223 | $108 | $210 |
| Annual depression screening | 205 | $20 | $28 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
203 | $55 | $200 |
| Initial nursing facility care, moderate complexity Initial care provided to a patient in a nursing facility with moderate medical decision making, taking at least 35 minutes. |
168 | $111 | $175 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
131 | $33 | $40 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
116 | $40 | $90 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
112 | $43 | $107 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
93 | $145 | $250 |
| Flu vaccine, quadrivalent A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection. |
75 | $76 | $100 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
61 | $6 | $14 |
| Routine 12-lead electrocardiogram (ECG) A test that records the electrical activity of the heart using at least 12 leads to produce a tracing. |
60 | $5 | $15 |
| Transitional care management services, moderate complexity Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity. |
56 | $59 | $181 |
| Quadrivalent influenza vaccine, cell-culture derived A flu shot containing four strains of influenza virus, produced using cell culture technology rather than eggs. This formulation is free from preservatives and antibiotics. |
55 | $33 | $50 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
38 | $66 | $103 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
30 | $63 | $88 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
20 | $10 | $31 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
18 | $10 | $20 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
16 | $99 | $150 |
| Home health plan of care certification Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians. |
16 | $37 | $64 |
| Hospital discharge day management, 30 minutes or less This service covers the final day of hospital care when the patient is being discharged. It includes coordination of care and instructions for the patient within a time frame of 30 minutes or less. |
15 | $68 | $127 |
| Initial nursing facility care, high complexity An initial visit by a healthcare provider to a patient in a nursing facility involving a high level of medical decision making, lasting at least 45 minutes. |
11 | $152 | $200 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$7,142
Total received (2018-2024)
Avg $1,020/year across 7 years
Top 11% in NJ for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
51
Companies
443
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,142 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,156
2023
$924
2022
$903
2021
$1,193
2020
$1,045
2019
$1,118
2018
$804
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$400
Becton, Dickinson and Company
$238
Amgen Inc.
$91
Novo Nordisk Inc
$90
GlaxoSmithKline, LLC.
$83
Otsuka America Pharmaceutical, Inc.
$50
PFIZER INC.
$46
Novartis Pharmaceuticals Corporation
$35
Paratek Pharmaceuticals, Inc.
$31
CVRx, Inc.
$23
Exact Sciences Corporation
$19
ABBVIE INC.
$19
Neurocrine Biosciences, Inc.
$16
Bayer Healthcare Pharmaceuticals Inc.
$15
Top 3 companies account for 63.1% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$1,388
Lilly USA, LLC
$776
Novo Nordisk Inc
$675
PFIZER INC.
$432
Boston Scientific Corporation
$336
Amarin Pharma Inc.
$304
GlaxoSmithKline, LLC.
$289
Novartis Pharmaceuticals Corporation
$262
Becton, Dickinson and Company
$238
Amgen Inc.
$190
Merck Sharp & Dohme Corporation
$180
Janssen Pharmaceuticals, Inc
$174
Silk Road Medical, Inc.
$122
E.R. Squibb & Sons, L.L.C.
$114
Allergan, Inc.
$110
Abbott Laboratories
$110
Teva Pharmaceuticals USA, Inc.
$109
AbbVie Inc.
$103
Sunovion Pharmaceuticals Inc.
$92
Boehringer Ingelheim Pharmaceuticals, Inc.
$77
HeartFlow, Inc.
$77
Exact Sciences Corporation
$74
Otsuka America Pharmaceutical, Inc.
$69
Scilex Pharmaceuticals Inc.
$66
Philips Electronics North America Corporation
$63
Radius Health, Inc.
$59
ACADIA Pharmaceuticals Inc
$56
Astellas Pharma US Inc
$47
Xeris Pharmaceuticals, Inc.
$45
Merck Sharp & Dohme LLC
$45
Paratek Pharmaceuticals, Inc.
$44
Avanir Pharmaceuticals, Inc.
$39
TOPCON HEALTHCARE SOLUTIONS, INC.
$32
ABBVIE INC.
$32
Bayer Healthcare Pharmaceuticals Inc.
$31
Takeda Pharmaceuticals U.S.A., Inc.
$26
Nabriva Therapeutics, plc
$26
UCB, Inc.
$25
Amneal Pharmaceuticals LLC
$23
CVRx, Inc.
$23
Biohaven Pharmaceuticals, Inc.
$20
Bayer HealthCare Pharmaceuticals Inc.
$17
Neurocrine Biosciences, Inc.
$16
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$15
Eisai Inc.
$15
Allergan Inc.
$15
Bausch Health US, LLC
$14
SANOFI-AVENTIS U.S. LLC
$14
Collegium Pharmaceutical, Inc.
$12
Kowa Pharmaceuticals America, Inc.
$11
Kyowa Kirin, Inc.
$11
Top 3 companies account for 39.8% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · AIRSUPRA · AJOVY · ANORO ELLIPTA · APLENZIN · APTIOM · AUSTEDO · Austedo XR · BAQSIMI · BASAGLAR · BELSOMRA · BREZTRI · Barostim Neo System · Briviact · CHANTIX · COLOGUARD DNA CAPTURE REAGENTS · Cologuard Collection Kit · Dayvigo · ELIQUIS · EMGALITY · ENROUTE Transcarotid Neuroprotection System · ENTRESTO · FARXIGA · FIASP · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · GVOKE HYPOPEN · GVOKE PFS · HUMALOG · INGREZZA · INVOKANA · JANUVIA · JARDIANCE · Kerendia · LEQVIO · LINZESS · LOKELMA · LONHALA MAGNAIR · LYRICA · Livalo · MOUNJARO · MYRBETRIQ · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · NUZYRA · Neupro · Nuedexta · Otezla · Ozempic · PADCEV · PAXLOVID · PREVNAR 20 · Phasix Mesh · QULIPTA · REXULTI · RYBELSUS · RYTARY · Repatha · Rybelsus · STIOLTO RESPIMAT · SUPERION · SYMBICORT · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · Tresiba · Trintellix · Tymlos · UBRELVY · UNITHROID · Utibron · VESICARE · VIBERZI · VRAYLAR · Vascepa · Victoza · WATCHMAN · WATCHMAN Access System · Wegovy · XARELTO · XIFAXAN · XTAMPZA · Xenleta · Xultophy 100/3.6 · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Internal medicine physicians within 10 mi
1,160
Per 100K population
179.4
County median income
$86,411
Nearest hospital
MONMOUTH MEDICAL CENTER-SOUTHERN CAMPUS
8.7 mi
8.7 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Shah is a clinical cardiology specialist, with above-average Medicare volume (top 5% in NJ), with low-engagement industry engagement in the top 11% of NJ peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Shah experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Shah performed 1,412 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Shah receive payments from pharmaceutical companies?
Yes. Dr. Shah received a total of $7,142 from 51 companies across 443 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Shah's costs compare to other internal medicine physicians in Jackson?
Dr. Shah's average Medicare payment per service is $61. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Shah) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Jackson
Browse internal medicine physicians in Jackson ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in NJ
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in NJ
Which NJ internal medicine physicians receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology